English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

headache/nausea

The link is saved to the clipboard
Page 1 from 33 results

Pharmaceutical compositions for headache, migraine, nausea and emesis

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of

Pharmaceutical compositions for headache, migraine, nausea and emesis

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of

Method and composition for treatment of headache using magnesium

Only registered users can translate articles
Log In/Sign up
BACKGROUND ART Magnesium (Mg) is the second most abundant cation in the body [Altura, B. M. et al., Drugs 28 (Suppl.I):120-142, 1984]. It is cofactor for more than 325 cellular enzymes involved in cellular energy production and storage, protein synthesis, DNA and RNA synthesis, cell growth and

Device, system and method for reducing headache pain

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Migraine headaches affect approximately 9% (21 million female; 7 million male) of the population in the United States. The worldwide estimate of incidence is 650 million. There are a number of different forms of migraine. A principal characteristic of all migraines is

Analgesic composition for treatment of migraine headaches

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to magnesium-based compositions for treating migraine headaches, and methods for using the same. BACKGROUND OF THE INVENTION Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the gastric

Analgesic composition for treatment of migraine headaches

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to magnesium-based analgesic compositions for treating migraine headaches, and methods for using the same. BACKGROUND OF THE INVENTION Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the

Treatment of migraine, cluster headaches and trigeminal neuralgia

Only registered users can translate articles
Log In/Sign up
This invention relates to a method of treatment of migraine, cluster headaches and trigeminal neuralgia, radiation or cytotoxic agent induced nausea and vomiting and/or cardiac arrhythmia in mammals, including humans, and to the use of compounds in the preparation of a medicament for the treatment

C.sub.14 Phenyl-substituted derivatives of prostaglandin analogues

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION 1. Field of the Invention The compounds of this invention are analogues of natural prostaglandins. Natural prostaglandins are salicyclic compounds related to prostanoic acid, the structure of which is: ##STR2## By convention, the carbon atoms of I are numbered

Treatment method

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell

Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell

Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell

Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention provides a prodrug of propofol and crystalline forms thereof, methods of making the propofol prodrug and crystalline forms thereof, pharmaceutical compositions of the propofol prodrug and crystalline forms thereof, methods of using the propofol

Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention provides a prodrug of propofol and crystalline forms thereof, methods of making the propofol prodrug and crystalline forms thereof, pharmaceutical compositions of the propofol prodrug and crystalline forms thereof, methods of using the propofol

Modulation of substance P by compounds containing calcium sulfate and methods relating thereto

Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD The present invention relates generally to a method of modulating substance P by compounds containing calcium sulfate, particularly syngenite, gorgeyite and gypsum, and more specifically, to the synthesis of such compounds as well as their use to treat a variety of conditions

Method for pain relief using low power laser light

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Although it is often said that the common cold is the most prevalent disease among humankind, it is also true that chronic pain is an affliction that is almost as prevalent. Chronic headaches, muscle pain, joint pain, and the like are experienced by most individuals, and
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge